Galectin Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-24.3M | $-24.3M | — | $2.1M |
| FY2022 | $-31.1M | $-31.1M | — | $2.9M |
| FY2023 | $-33.0M | $-33.0M | — | $2.3M |
| FY2024 | $-41.8M | $-41.8M | — | $2.4M |
| FY2025 | $-23.9M | $-23.9M | — | $1.7M |